Bisht Kamal Kumar, Patel Priyank, Rachuri Yadagiri, Eringathodi Suresh
Analytical Discipline and Centralized Instrument Facility, CSIR - Central Salt and Marine Chemicals Research Institute, Council of Scientific and Industrial Research, G. B. Marg, Bhavnagar 364 002, Gujarat, India.
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2014 Feb;70(Pt 1):63-71. doi: 10.1107/S2052520613031260. Epub 2014 Jan 16.
Co-crystals comprising the active pharmaceutical ingredient 1,4-bis(4-pyridyl)-2,3-diaza-1,3-butadiene, C12H10N4, and the chiral co-formers (+)-, (-)- and (rac)-camphoric acid (cam), C10H16O4, have been synthesized. Two different stoichiometries of the API and co-former are obtained, namely 1:1 and 3:2. Crystallization experiments suggest that the 3:2 co-crystal is kinetically favoured over the 1:1 co-crystal. Single-crystal X-ray diffraction analysis of the co-crystals reveals N-H...O hydrogen bonding as the primary driving force for crystallization of the supramolecular structures. The 1:1 co-crystal contains undulating hydrogen-bonded ribbons, in which the chiral cam molecules impart a helical twist. The 3:2 co-crystal contains discrete Z-shaped motifs comprising three molecules of the API and two molecules of cam. The 3:2 co-crystals with (+)-cam, (-)-cam (space group P21) and (rac)-cam (space group P21/n) are isostructural. The enantiomeric co-crystals contain pseudo-symmetry consistent with space group P21/n, and the co-crystal with (rac)-cam represents a solid solution between the co-crystals containing (+)-cam and (-)-cam.
已合成了由活性药物成分1,4 - 双(4 - 吡啶基)-2,3 - 二氮杂-1,3 - 丁二烯(C₁₂H₁₀N₄)和手性共形成物(+)-、(-)-和(外消旋)-樟脑酸(cam,C₁₀H₁₆O₄)组成的共晶体。获得了活性药物成分与共形成物的两种不同化学计量比,即1:1和3:2。结晶实验表明,3:2共晶体在动力学上比1:1共晶体更有利。共晶体的单晶X射线衍射分析表明,N - H...O氢键是超分子结构结晶的主要驱动力。1:1共晶体包含起伏的氢键连接带,其中手性樟脑分子赋予螺旋扭曲。3:2共晶体包含由三个活性药物成分分子和两个樟脑分子组成的离散Z形基序。具有(+)-cam、(-)-cam(空间群P2₁)和(外消旋)-cam(空间群P2₁/n)的3:2共晶体是同构的。对映体共晶体包含与空间群P2₁/n一致的伪对称性,并且具有(外消旋)-cam的共晶体代表包含(+)-cam和(-)-cam的共晶体之间的固溶体。